arrow
F

Franziska Eckert

Medical University of Vienna
H指数:30
被引数:2,770

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Immune remodelling and molecular profiling of progressive brain metastases following cranial radiotherapy

颅脑放射治疗后进展性脑转移瘤的免疫重塑与分子特征分析

2026-08-010
PRE
ESTRO clinical practice guideline on radiotherapy for adult soft tissue sarcoma of the extremities and trunk wall – Endorsed by ASTRO

欧洲放射肿瘤学会(ESTRO)关于四肢和躯干壁成人软组织肉瘤放射治疗的临床实践指南——美国放射肿瘤学会(ASTRO)认可

2026-04-160
PRE
Clinical potential of [18F]FET PET in patients with circumscribed astrocytic glioma

[18F]FET PET在局限性星形细胞胶质瘤患者中的临床潜力

2025-11-180
OAAI
CLINICAL UTILITY OF [18F]FET PET IN PATIENTS WITH CIRCUMSCRIBED ASTROCYTIC GLIOMA

[18F]FET PET在局限性星形细胞胶质瘤患者中的临床应用价值

2025-10-010
OA
A PERSONALIZED TARGETED GLIOBLASTOMA THERAPIES BY EX VIVO DRUG SCREENING: ADVANCED BRAIN TUMOR THERAPY CLINICAL TRIAL (ATTRACT)

通过体外药物筛选实现的个性化靶向胶质母细胞瘤疗法:高级脑肿瘤疗法临床试验(ATTRACT)

2025-10-010
OAAI
The sarcoma ring trial: a case-based analysis of inter-center agreement across 21 German-speaking sarcoma centers (vol 151, 30, 2024)

软组织肉瘤环状试验:一项基于病例的分析,评估德国21个讲德语的软组织肉瘤中心之间的中心间一致性(卷151,期30,2024)

2025-04-240
OA
Detection of H3F3A K27M or BRAF V600E in liquid biopsies of brain tumor patients as diagnostic and monitoring biomarker: impact of tumor localization and sampling method

脑肿瘤患者液体活检中H3F3A K27M或BRAF V600E的检测作为诊断和监测生物标志物:肿瘤定位和采样方法的影响

2025-01-030
OA
Alternative lengthening of telomere-based immortalization renders H3G34R-mutant diffuse hemispheric glioma hypersensitive to PARP inhibitor combination regimens
2024-11-180
PRE
AMINO-ACID PET VERSUS MRI GUIDED RE-IRRADIATION IN PATIENTS WITH RECURRENT GLIOBLASTOMA - GLIAA TRIAL (NOA 10/ARO 2013-1, DKTK-A)
2024-10-170
PRE